{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:33:31Z","timestamp":1791725611587,"version":"4.3.4"},"reference-count":41,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,2,16]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>CCR5 blockade decreases peripheral T-cell activation, gut GVHD biomarkers, and acute GVHD incidence in allo-HSCT recipients. CXCR3-mediated lymphocyte trafficking may represent an important resistance mechanism to CCR5 blockade in GVHD prophylaxis.<\/jats:p>","DOI":"10.1182\/blood-2016-08-735076","type":"journal-article","created":{"date-parts":[[2017,1,6]],"date-time":"2017-01-06T03:00:30Z","timestamp":1483671630000},"page":"906-916","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":71,"title":["Clinical and immunologic impact of CCR5 blockade in graft-versus-host disease prophylaxis"],"prefix":"10.1182","volume":"129","author":[{"given":"Ryan H.","family":"Moy","sequence":"first","affiliation":[{"name":"Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA;"},{"name":"Department of Medicine, New York-Presbyterian Hospital\u2013Weill Cornell Medical College, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin P.","family":"Huffman","sequence":"additional","affiliation":[{"name":"Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA;"},{"name":"Division of Hematology\/Oncology and"},{"name":"Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee P.","family":"Richman","sequence":"additional","affiliation":[{"name":"Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Crisalli","sequence":"additional","affiliation":[{"name":"Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ximi K.","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology and"},{"name":"Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Hoxie","sequence":"additional","affiliation":[{"name":"Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemarie","family":"Mick","sequence":"additional","affiliation":[{"name":"Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA;"},{"name":"Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen G.","family":"Emerson","sequence":"additional","affiliation":[{"name":"Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Temple University, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Vonderheide","sequence":"additional","affiliation":[{"name":"Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Porter","sequence":"additional","affiliation":[{"name":"Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Reshef","sequence":"additional","affiliation":[{"name":"Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA;"},{"name":"Division of Hematology\/Oncology and"},{"name":"Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, New York, NY;"},{"name":"Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"9674","key":"2019111904494582100_B1","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0140-6736(09)60237-3","article-title":"Graft-versus-host disease","volume":"373","author":"Ferrara","year":"2009","journal-title":"Lancet"},{"issue":"2","key":"2019111904494582100_B2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.beha.2008.02.006","article-title":"Acute graft-versus-host disease: differing risk with differing graft sources and conditioning intensity","volume":"21","author":"Johnston","year":"2008","journal-title":"Best Pract Res Clin Haematol"},{"issue":"11","key":"2019111904494582100_B3","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1182\/blood-2004-12-4726","article-title":"Leukocyte migration and graft-versus-host disease","volume":"105","author":"Wysocki","year":"2005","journal-title":"Blood"},{"issue":"1","key":"2019111904494582100_B4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1172\/JCI6642","article-title":"Active participation of CCR5(+)CD8(+) T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease","volume":"104","author":"Murai","year":"1999","journal-title":"J Clin Invest"},{"issue":"2","key":"2019111904494582100_B5","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ni879","article-title":"Peyer\u2019s patch is the essential site in initiating murine acute and lethal graft-versus-host reaction","volume":"4","author":"Murai","year":"2003","journal-title":"Nat Immunol"},{"issue":"11","key":"2019111904494582100_B6","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1182\/blood-2009-08-237768","article-title":"Donor and recipient chemokine receptor CCR5 genotype is associated with survival after bone marrow transplantation","volume":"115","author":"McDermott","year":"2010","journal-title":"Blood"},{"issue":"1","key":"2019111904494582100_B7","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.bbmt.2009.05.017","article-title":"CCR5 expression on cells from HLA-matched unrelated marrow donors and graft-versus-host disease","volume":"16","author":"Ma","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"2019111904494582100_B8","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/bjh.13387","article-title":"CCR5 gene polymorphism affects the risk of GvHD after haematopoietic stem cell transplantation from an unrelated donor","volume":"171","author":"Bogunia-Kubik","year":"2015","journal-title":"Br J Haematol"},{"issue":"2","key":"2019111904494582100_B9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJMoa1201248","article-title":"Blockade of lymphocyte chemotaxis in visceral graft-versus-host disease","volume":"367","author":"Reshef","year":"2012","journal-title":"N Engl J Med"},{"issue":"6","key":"2019111904494582100_B10","first-page":"825","article-title":"1994 Consensus Conference on Acute GVHD Grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"2019111904494582100_B11","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6754","key":"2019111904494582100_B12","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/44385","article-title":"Two subsets of memory T lymphocytes with distinct homing potentials and effector functions","volume":"401","author":"Sallusto","year":"1999","journal-title":"Nature"},{"key":"2019111904494582100_B13","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1146\/annurev.immunol.22.012703.104702","article-title":"Central memory and effector memory T cell subsets: function, generation, and maintenance","volume":"22","author":"Sallusto","year":"2004","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"2019111904494582100_B14","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A class of K-sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"Gray","year":"1988","journal-title":"Ann Stat"},{"issue":"4","key":"2019111904494582100_B15","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1182\/blood-2012-03-418202","article-title":"A disease risk index for patients undergoing allogeneic stem cell transplantation","volume":"120","author":"Armand","year":"2012","journal-title":"Blood"},{"issue":"suppl 1","key":"2019111904494582100_B16","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1016\/j.bbmt.2011.10.019","article-title":"Clinical applications for biomarkers of acute and chronic graft-versus-host disease","volume":"18","author":"Levine","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"2019111904494582100_B17","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2352-3026(14)00035-0","article-title":"A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study","volume":"2","author":"Levine","year":"2015","journal-title":"Lancet Haematol"},{"issue":"25","key":"2019111904494582100_B18","doi-asserted-by":"crossref","first-page":"6702","DOI":"10.1182\/blood-2011-08-375006","article-title":"Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease","volume":"118","author":"Ferrara","year":"2011","journal-title":"Blood"},{"issue":"4","key":"2019111904494582100_B19","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1182\/blood-2008-02-138867","article-title":"Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival","volume":"112","author":"Choi","year":"2008","journal-title":"Blood"},{"issue":"6","key":"2019111904494582100_B20","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1056\/NEJMoa1213299","article-title":"ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death","volume":"369","author":"Vander Lugt","year":"2013","journal-title":"N Engl J Med"},{"key":"2019111904494582100_B21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1146\/annurev-immunol-032712-100010","article-title":"The biology of recent thymic emigrants","volume":"31","author":"Fink","year":"2013","journal-title":"Annu Rev Immunol"},{"issue":"13","key":"2019111904494582100_B22","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1182\/blood-2011-05-352708","article-title":"Human regulatory T cells in allogeneic stem cell transplantation","volume":"118","author":"Ukena","year":"2011","journal-title":"Blood"},{"issue":"9","key":"2019111904494582100_B23","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1182\/blood-2005-04-1632","article-title":"Critical role for CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host disease","volume":"106","author":"Wysocki","year":"2005","journal-title":"Blood"},{"issue":"3","key":"2019111904494582100_B24","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/jac\/dks432","article-title":"In vitro effects of the CCR5 inhibitor maraviroc on human T cell function","volume":"68","author":"Arberas","year":"2013","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"2019111904494582100_B25","doi-asserted-by":"crossref","first-page":"R149","DOI":"10.1186\/ar2823","article-title":"Chemokine receptor expression and functional effects of chemokines on B cells: implication in the pathogenesis of rheumatoid arthritis","volume":"11","author":"Nanki","year":"2009","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"2019111904494582100_B26","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0301-472X(03)00198-X","article-title":"Role of CXCR3-induced donor T-cell migration in acute GVHD","volume":"31","author":"Duffner","year":"2003","journal-title":"Exp Hematol"},{"issue":"12","key":"2019111904494582100_B27","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1182\/blood-2006-12-061408","article-title":"CXCL10-CXCR3 interactions play an important role in the pathogenesis of acute graft-versus-host disease in the skin following allogeneic stem-cell transplantation","volume":"110","author":"Piper","year":"2007","journal-title":"Blood"},{"issue":"20","key":"2019111904494582100_B28","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1182\/blood-2012-02-413260","article-title":"Chemokine-mediated tissue recruitment of CXCR3+ CD4+ T cells plays a major role in the pathogenesis of chronic GVHD","volume":"120","author":"Croudace","year":"2012","journal-title":"Blood"},{"issue":"1","key":"2019111904494582100_B29","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1172\/JCI17601","article-title":"Memory CD4+ T cells do not induce graft-versus-host disease","volume":"112","author":"Anderson","year":"2003","journal-title":"J Clin Invest"},{"issue":"23","key":"2019111904494582100_B30","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.1182\/blood-2009-12-260539","article-title":"Leukemia-associated minor histocompatibility antigen discovery using T-cell clones isolated by in vitro stimulation of naive CD8+ T cells","volume":"115","author":"Bleakley","year":"2010","journal-title":"Blood"},{"issue":"2","key":"2019111904494582100_B31","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1182\/blood-2004-05-1687","article-title":"Donor-derived IL-15 is critical for acute allogeneic graft-versus-host disease","volume":"105","author":"Blaser","year":"2005","journal-title":"Blood"},{"issue":"10","key":"2019111904494582100_B32","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1038\/bmt.2010.300","article-title":"Plasma levels of IL-7 and IL-15 after reduced intensity conditioned allo-SCT and relationship to acute GVHD","volume":"46","author":"Thiant","year":"2011","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"2019111904494582100_B33","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1074-7613(00)80165-X","article-title":"Chemokines: a new classification system and their role in immunity","volume":"12","author":"Zlotnik","year":"2000","journal-title":"Immunity"},{"issue":"23","key":"2019111904494582100_B34","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1182\/blood-2012-06-436345","article-title":"The immunologic effects of maraviroc intensification in treated HIV-infected individuals with incomplete CD4+ T-cell recovery: a randomized trial","volume":"121","author":"Hunt","year":"2013","journal-title":"Blood"},{"issue":"11","key":"2019111904494582100_B35","doi-asserted-by":"crossref","first-page":"7581","DOI":"10.4049\/jimmunol.181.11.7581","article-title":"A new approach to the blocking of alloreactive T cell-mediated graft-versus-host disease by in vivo administration of anti-CXCR3 neutralizing antibody","volume":"181","author":"He","year":"2008","journal-title":"J Immunol"},{"key":"2019111904494582100_B36","author":"Hartwell"},{"issue":"7","key":"2019111904494582100_B37","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1172\/JCI81229","article-title":"Outcomes of acute leukemia patients transplanted with naive T cell-depleted stem cell grafts","volume":"125","author":"Bleakley","year":"2015","journal-title":"J Clin Invest"},{"issue":"4","key":"2019111904494582100_B38","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.bbmt.2014.01.002","article-title":"Immune cell subset counts associated with graft-versus-host disease","volume":"20","author":"Podgorny","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"2019111904494582100_B39","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1182\/blood-2015-10-672345","article-title":"Unbalanced recovery of regulatory and effector T cells after allogeneic stem cell transplantation contributes to chronic GVHD","volume":"127","author":"Alho","year":"2016","journal-title":"Blood"},{"issue":"12","key":"2019111904494582100_B40","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1038\/bmt.2015.191","article-title":"Identification and validation of biomarkers associated with acute and chronic graft versus host disease","volume":"50","author":"Ahmed","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"2019111904494582100_B41","doi-asserted-by":"crossref","first-page":"845","DOI":"10.4049\/jimmunol.173.2.845","article-title":"Differential roles for CCR5 expression on donor T cells during graft-versus-host disease based on pretransplant conditioning","volume":"173","author":"Wysocki","year":"2004","journal-title":"J Immunol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/7\/906\/1402182\/blood735076.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/7\/906\/1402182\/blood735076.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T09:50:03Z","timestamp":1574157003000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/129\/7\/906\/36197\/Clinical-and-immunologic-impact-of-CCR5-blockade"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,16]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,2,16]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2016-08-735076","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,16]]}}}